1H NMR
It involves the detection of hydrogen (1H) nuclei within a molecule, providing information about the chemical environment and connectivity of these hydrogen atoms. 1H NMR is widely applied in chemistry, biochemistry, and pharmaceutical research to elucidate the structure and purity of compounds, as well as to monitor chemical reactions and study biomolecular interactions.
The technique relies on the magnetic properties of hydrogen nuclei, which can be detected and analyzed using specialized instrumentation. 1H NMR spectra offer a wealth of information, including chemical shift, coupling patterns, and signal intensities, allowing researchers to make informed decisions about the optimal conditions and products for their experiments.
By streamlining the research process with AI-powered tools like PubCompare.ai, scientists can quickly locate the best 1H NMR protocols from literature, pre-prits, and patents, and identify the ideal conditions for their specific applications.
Most cited protocols related to «1H NMR»
literature values, specifically, the human metabolome database,17 (link) the biological magnetic resonance data bank,18 (link) and publications from our laboratory on the
serum metabolome.7 (link),19 (link) Unknown metabolite identification
involved a combination of literature/database searches,17 (link) chemical shift, peak multiplicity, and J couplings measurements, and comprehensive 2D DQF-COSY
and TOCSY spectral analyses. The putative new compounds were finally
confirmed by spiking with authentic compounds (see
(version 5.1; Chenomx Inc., Edmonton, Alberta, Canada) was used to
quantitate the metabolites. This software allows fitting spectral
lines using the standard metabolite library for 800 MHz 1H NMR spectra and, in particular, the determination of concentrations
in complicated, overlapped spectral regions. One complication that
arises is that the proximity of chemical shift values for multiple
metabolite signals often result in the software providing multiple
library hits for the same metabolite peak; the correct metabolite
identification therefore relied on the newly established metabolite
identification as annotated for a typical 1H NMR spectrum
(vide infra). Peak-fitting with reference to the internal TSP signal
enabled the determination of absolute concentrations for identified
metabolites in protein-precipitated serum except for 2-oxoisovaleric,
which was absent in the Chenomx library and was therefore quantitated
by manual integration using the Bruker Topspin versions 3.0 or 3.1
software package.
of the NMR processing functions of MVAPACK was performed by visually
comparing the MVAPACK-processed 1D 1H NMR spectra from
the Coffees data set (Figure
NMR spectra produced by ACD/1D NMR Manager (Advanced Chemistry Development).
Verification of icoshift alignment
performance was performed using
the Wine 1H NMR data set42 available
from the University of Copenhagen. As this data set contains large
amounts of chemical shift dispersion due to differences in chemical
properties of each wine, it is an ideal basis for assessing the performance
of NMR peak alignment algorithms (Figure
Validation of the proper operation of PCA, PLS and OPLS multivariate
decompositions was performed by comparing the scores produced by analysis
of the Coffees NMR data set in MVAPACK with those produced by SIMCA-P+
13.0 (Umetrics AB, Umea, Sweden) (Figures
Most recents protocols related to «1H NMR»
Example 21
Complex Em9-i:
A solution of 0.17 g of complex Em9-s in 2000 ml acetonitril are irradiated at 15° C. for 9.5 h with a blacklight-blue-lamp (Osram, L18W/73, λmax=370-380 nm). The solvent is removed in vacuo. The residue is purified by chromatography (cyclohexane/acetic ester). 0.055 g of Em9-i (32%, contaminated with traces of a further complex) are obtained as well as 0.075 g of reisolated Em9-s (44%) are reisolated.
1H-NMR [CD2Cl2, 400 MHz, sample comprises traces of a further complex observable for example at 0.77 (m), 0.83 (d), 1.04 (d), 1.21 (m), 1.92 (sept), 2.34 (sept), 7.20-7.23 (m), 7.31-7.34 (m)]:
δ=0.65 (d, 3H), 0.77 (d, 3H), 0.85 (d, 3H), 0.97 (d, 3H), 0.98 (d, 3H), 1.02 (d, 3H), 1.13 (d, 6H), 1.82 (sept, 1H), 2.33 (sept, 1H), 2.54 (sept, 1H), 2.67 (sept, 1H), 3.04 (s, 3H), 6.09 (dd, 2H), 6.37 (td, 1H), 6.40-6.44 (m, 3H), 6.50 (m, 1H), 6.59 (d, 1H), 6.61 (td, 1H), 6.68 (d, 1H), 6.70 (d, 1H), 6.72 (d, 1H), 6.86 (d, 1H), 6.96 (br.s, 1H), 7.14 (me, 2H), 7.20-7.23 (m, 1H), 7.23-7.31 (m, 3H), 7.44-7.50 (m, 3H).
MS (Maldi):
m/e=979 (M+H)+
photoluminescence (in film, 2% in PMMA):
λmax=457, 485 nm, CIE: (0.17; 0.26)
The photoluminescence quantum efficiency of the isomer Em9-i has the 1.14-fold value of the quantum efficiency of the isomer Em9-s.
Example 30
To a stirred solution of 3-(3,4-dimethoxyphenyl)-5-(4-piperidyl)-1,2,4-oxadiazole (150 mg, 518 μmol) in N,N-dimethylformamide (1.50 mL) were added (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) (196 mg, 518 μmol), N-ethyl-N-(propan-2-yl)propan-2-amine (201 mg, 1.56 mmol, 271 μL), and 2-(benzylamino)acetic acid (89 mg, 544 μmol). The mixture was stirred at 20° C. for 16 h and filtered, and the crude filtrate was purified directly by prep-HPLC (column: Luna C8 100×30 5 μm; mobile phase: [water (10 mM ammonium carbonate)-acetonitrile]; B%: 30%-60%, 12 min) to give 2-(benzylamino)-1-[4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidyl]ethanone (48 mg, 110 μmol, 21%) as a yellow solid. 1H NMR (400 MHz, METHANOL-d4) δ=7.65 (dd, J=1.8, 8.2 Hz, 1H), 7.57 (d, J=1.8 Hz, 1H), 7.40-7.30 (m, 4H), 7.28-7.22 (m, 1H), 7.06 (d, J=8.4 Hz, 1H), 4.45 (br d, J=13.7 Hz, 1H), 3.94-3.83 (m, 7H), 3.78 (s, 2H), 3.57-3.44 (m, 2H), 3.40-3.33 (m, 1H), 3.27-3.20 (m, 1H), 3.01 (t, J=11.2 Hz, 1H), 2.17 (dd, J=2.8, 13.3 Hz, 2H), 1.93-1.73 (m, 2H); LCMS (ESI) m/z: [M+H]+=437.3.
Example 161
To a solution of 2-(piperazin-1-yl)ethanol (0.73 g, 5.6 mmol, 1 eq.) in DMF (10 mL) was added K2CO3 (1.56 g, 11.3 mmol, 2 eq.) followed by 1,2,4-trifluoro-5-nitrobenzene (1 g, 5.6 mmol, 1 eq.) and the mixture was stirred at 0° C. for 1 hour. The mixture was poured into ice-water (100 mL), extracted by EA (3×40 mL), and the organic layers were combined, washed with brine (150 mL), concentrated and purified via column chromatography (10-95% CH3CN—H2O) to afford 2-(4-(2,5-difluoro-4-nitrophenyl)piperazin-1-yl)ethanol (0.65 g, 41%) as a yellow solid.
To a solution of 2-(4-(2,5-difluoro-4-nitrophenyl)piperazin-1-yl)ethanol (0.65 g, 2.3 mmol) in MeOH (50 mL) was added Pd/C (100 mg) and the resulting mixture was stirred at r.t. overnight. The Pd/C was removed by filtration and the filtrate was concentrated to afford 2-(4-(4-amino-2,5-difluorophenyl)piperazin-1-yl)ethanol (0.58 g, 99%).
To a suspension of 2-(4-(4-amino-2,5-difluorophenyl)piperazin-1-yl)ethanol (270 mg, 0.88 mmol, 1 eq.) and N-(3-(2-chloroquinazolin-8-yl)phenyl)acrylamide (225 mg, 0.88 mmol, 1 eq.) in n-BuOH (10 mL) was added TFA (0.5 mL, 4.4 mmol, 5 eq.) and the resulting mixture was stirred at 90° C. overnight. The mixture was concentrated, diluted with DCM (20 mL), washed with Na2CO3 solution (20 mL), dried, concentrated and purified via column chromatography (DCM/MeOH=10/1) to afford N-(3-(2-((2,5-difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide (120 mg, 26%) as yellow solid. LRMS (M+H+) m/z calculated 531.2, found 531.2. 1H NMR (DMSO-d6, 400 MHz) δ 10.18 (s, 1H), 9.37 (s, 1H), 9.17 (s, 1H), 7.97-7.94 (m, 3H), 7.83-7.74 (m, 2H), 7.50-7.39 (m, 3H), 6.90-6.85 (m, 1H), 6.48-6.41 (m, 1H), 6.23 (dd, 1H), 5.73 (dd, 1H), 4.42 (t, 1H), 3.55-3.50 (m, 2H), 2.94-2.91 (m, 4H), 2.55-2.54 (m, 4H), 2.44 (t, 2H).
Example 1
InCl (1 eq.) was added to a Schlenk flask charged with LiCp(CH2)3NMe2 (11 mmol) in Et2O (50 mL). The reaction mixture was stirred overnight at room temperature. After filtration of the reaction mixture, the solvent was evaporated under reduced pressure to obtain a red oil. After distillation a yellow liquid final product was collected (mp˜5° C.). Various measurements were done to the final product. 1H NMR (C6D6, 400 MHz): δ 5.94 (t, 2H, Cp-H), 5.82 (t, 2H, Cp-H), 2.52 (t, 2H, N—CH2—), 2.21 (t, 2H, Cp-CH2—), 2.09 (s, 6H, N(CH3)2, 1.68 (q, 2H, C—CH2—C). Thermogravimetric (TG) measurement was carried out under the following measurement conditions: sample weight: 22.35 mg, atmosphere: N2 at 1 atm, and rate of temperature increase: 10.0° C./min. 97.2% of the compound mass had evaporated up to 250° C. (Residue <2.8%). T (50%)=208° C. Vacuum TG measurement was carried out under delivery conditions, under the following measurement conditions: sample weight: 5.46 mg, atmosphere: N2 at 20 mbar, and rate of temperature increase: 10.0° C./min. TG measurement was carried out under delivery conditions into the reactor (about 20 mbar). 50% of the sample mass is evaporated at 111° C.
Using In(Cp(CH2)3NMe2) synthesized in Example 1 as an indium precursor and H2O and O3 as reaction gases, indium oxide film may be formed on a substrate by ALD method under the following deposition conditions. First step, a cylinder filled with In(Cp(CH2)3NMe2) is heated to 90° C., bubbled with 100 sccm of N2 gas and the In(Cp(CH2)3NMe2) is introduced into a reaction chamber (pulse A). Next step, O3 generated by an ozone generator is supplied with 50 sccm of N2 gas and introduced into the reaction chamber (pulse B). Following each step, a 4 second purge step using 200 sccm of N2 as a purge gas was performed to the reaction chamber. 200 cycles were performed on a Si substrate having a substrate temperature of 150° C. in the reaction chamber at a pressure of about 1 torr. As a result, an indium oxide film will be obtained at approximately 150° C.
Example 2
Same procedure as Example 1 started from Li(CpPiPr2) was performed to synthesize In(CpPiPr2). An orange liquid was obtained. 1H NMR (C6D6, 400 MHz): δ 6.17 (t, 2H, Cp-H), 5.99 (t, 2H, Cp-H), 1.91 (sept, 2H, P—CH—), 1.20-1.00 (m, 12H, C—CH3).
Using In(CpPiPr2) synthesized in Example 2 as the indium precursor and H2O and O3 as the reaction gases, indium oxide film may be formed on a substrate by the ALD method under the following deposition conditions. First step, a cylinder filled with In(CpPiPr2) is heated to 90° C., bubbled with 100 sccm of N2 gas and the In(CpPiPr2) is introduced into a reaction chamber (pulse A). Next step, O3 generated by an ozone generator is supplied with 50 sccm of N2 gas and introduced into the reaction chamber (pulse B). Following each step, a 4 second purge step using 200 sccm of N2 as a purge gas was performed to the reaction chamber. 200 cycles were performed on the Si substrate having a substrate temperature of 150° C. in an ALD chamber at a pressure of about 1 torr. As a result, an indium oxide was obtained at 150° C.
Example 1
10 g (33.09 mmol) of 1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione (III), 6.8 g (49.62 mmol) of K2CO3 and 2.4 g (6.6 mmol) of tetrabutylammonium iodide were mixed with 50 mL of acetone at the temperature of about 20° C. Subsequently, 13.6 g (43.12 mmol) of (R)-2-((tert-butoxycarbonyl)amino)-2-phenylethyl methanesulfonate (IVa) were added and the obtained mixture was heated at the temperature of about 55° C. and maintained under stirring for about 16 hours at said temperature.
Once this maintenance was finished, the solvent was vacuum distilled and 50 mL of ethyl acetate and 50 mL of water were added to the residue thus obtained. A 1 M aqueous solution of HCl was slowly added, maintaining the temperature between 20 and 25° C. until achieving a pH of between 7 and 8. The aqueous phase was separated and treated with 3 fractions of 30 mL each of ethyl acetate. All the organic extracts were pooled and the solvent was removed by means of vacuum to obtain a slightly yellowish oily residue to which 45 mL of methanol were added, obtaining complete dissolution of the residue.
Example 2
16.1 g (99.24 mmol) of iodine monochloride (ICI) were dissolved in 40 mL of methanol at the temperature of about 10° C. The methanol solution previously obtained according to the methodology described in Example 1 comprising 3-((R)-2-(tert-butoxycarbonyl)amino-2-phenylethyl)-1-(2-fluoro-6-trifluoromethylbenzyl)-6-methyl-1H-pyrimidine-2,4-dione (II) was added to the iodine monochloride solution, maintaining the temperature between 20 and 25° C. Once the addition was finished, the obtained solution was heated to about 50° C. and was maintained under stirring for 2 hours at the mentioned temperature.
Once the maintenance was finished, the solvent was vacuum distilled and 50 mL of acetone were slowly added to the obtained oily residue at the temperature of between and 25° C. The addition of acetone caused a solid precipitate to appear almost immediately. The obtained mixture was maintained for 1 hour under stirring at the mentioned temperature. The resulting solid was isolated by filtration, washed with two fractions of 25 mL of acetone, and finally dried at the temperature of 50° C. to obtain 15.6 g (80.8% yield) of a white solid corresponding to the 3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6-trifluoromethylbenzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione hydrochloride salt (Ia) (UHPLC purity: 98.9%).
1H-NMR (d6-DMSO, 400 MHz) δ (ppm): 8.70 (2H, s broad), 7.65-7.48 (3H, m), 7.40-7.32 (5H, m), 5.40-5.29 (2H, dd), 4.47 (1H, t), 4.25 (2H, dd), 2.65 (3H, s).
13C-NMR (d6-DMSO, 100 MHz) δ (ppm): 161.87, 159.47, 159.41, 154.19, 150.98, 134.70, 129.93, 129.84, 129.01, 128.58, 127.38, 122.61, 122.34, 122.22, 121.34, 121.10, 74.80, 52.26, 45.45, 44.60, 25.66.
The DSC of this compound is shown in
Top products related to «1H NMR»
More about "1H NMR"
This non-destructive method relies on the magnetic properties of hydrogen nuclei, providing valuable information about the chemical environment and connectivity of these atoms within a molecule. 1H NMR spectroscopy offers a wealth of data, including chemical shift, coupling patterns, and signal intensities, which researchers can use to elucidate the structure and purity of compounds, as well as monitor chemical reactions and study biomolecular interactions.
The technique is often employed in conjunction with other analytical tools, such as 13C NMR, mass spectrometry, and infrared spectroscopy, to obtain a comprehensive understanding of a sample.
The 1H NMR process involves placing a sample in a strong magnetic field generated by specialized instrumentation, such as the Avance III, Avance 400, or AV-400 spectrometers.
The hydrogen nuclei within the sample align with the magnetic field, and when exposed to a specific radio frequency, they absorb and re-emit energy, producing a spectrum that can be analyzed.
To prepare samples for 1H NMR analysis, common techniques include dissolving the compound in deuterated solvents, such as chloroform-d or dimethyl sulfoxide-d6, and using silica gel 60 or XBridge C18 columns for purification.
The resulting 1H NMR spectra can be processed and interpreted using software like Topspin 3.2, providing researchers with valuable insights into the structure and purity of their samples.
By leveraging AI-powered tools like PubCompare.ai, scientists can streamline their 1H NMR research by quickly locating the best protocols from literature, pre-prInts, and patents, and identifying the optimal conditions for their specific applications.
This helps to accelerate the research process and ensure the efficient use of resources.